<<Disclaimer: Verify this information before applying it to your situation.>>

At-Home Finger-Stick IgG ELISA Food Intolerance Test Proven to Reduce
Symptoms of Irritable Bowel Syndrome

HOLLYWOOD, FL--July 1, 2003--Irritable Bowel Syndrome (IBS) has been
reported to affect at least 15% the population. In fact, it is so common
that surveys reveal that about half of the people attending hospital
out-patient departments with digestive problems are suffering from IBS.
Symptoms can include: abdominal pain and spasm, diarrhea, constipation,
bloating, flatulence, incontinence, nausea, belching and vomiting.
Secondary symptoms include panic attacks, anxiety and depression.

In addition to the pain, discomfort and embarrassment experienced by
patients with IBS, the costs for patients, health services, and industry
are significant. In the UK alone, it is estimated that the cost to
society are in excess of GBP 250m ($375m) per year and growing. In 1998,
in the United States, the average total cost (direct plus indirect) per
patient with IBS was over $4500. The costs to the physician and the
employer, including absenteeism were in excess of $2500. (Leong SA,
Barghout V, Birnhaum HG, Thibeault CE, Ben-Hamadi R, Frech F and Ofman
JJ. Arch Intern Med 2003 Apr 24;163(8):929-35)

Although there is greater awareness of IBS and its effect on the quality
of life, there is still no cure. Medical treatment may vary from advice
on diet and relaxation to the use of anti-spasmodic drugs or bulking
agents.

Until now, many IBS sufferers had little hope of getting symptomatic
relief, with or without drugs. They would spend time and money trying to
find ways to feel better - often ending up feeling even more frustrated
and depressed. Patients often ask what can they do to alter their diet
to alleviate their symptoms. The results of a recent double blind,
randomized, controlled clinical trial designed and conducted by
University Hospital of South Manchester, located in the UK, were
unveiled at Digestive Disease Week 2003 in Orlando, Florida, USA on May
19, 2003 and offers hope and relief to many thousands of people
suffering from IBS.

The Trial and its Results

This study assessed the effectiveness of an exclusion diet based on the
foodSCAN IgG ELISA Food Intolerance Test for the presence of IgG
antibodies in patients with IBS. Patients were given either a diet that
was based on the actual test results or was a placebo diet. Recordings
were taken on severity of symptoms, anxiety/depression and quality of
life measurements. The results show that the true diet was significantly
superior to the placebo diet in reducing severity of symptoms. Those who
adhered to the true diet showed greater improvement in symptomatic
relief than those who adhered to the placebo diet. The conclusion is
that a clinically significant improvement can be achieved in patients
with IBS using a food elimination diet based on IgG food antibodies.

According to Professor Trevor Sheldon, Department of Health Sciences,
University of York, "This double blind placebo controlled randomized
trial of 150 patients suffering from IBS showed significant improvements
for those who followed the dietary recommendations compared to those
people who followed a sham diet. People, who acted upon the test
results, significantly benefited. It proves that food elimination can
improve symptoms of IBS." "This is the first time a commercially
available blood test for food intolerance has been subjected to
scientific scrutiny in patients with irritable bowel syndrome. In a
controlled trial, patients eliminating foods to which they had
antibodies as determined by Yorktest Laboratories experienced a
significant improvement in their symptoms, providing evidence that this
approach may be very valuable in treating this condition," Dr. PJ
Whorwell, Consultant Gastroenterologist, University Hospital of South
Manchester.

What This Means

Dietary intervention can significantly improve symptoms of patients
suffering from IBS. By using the foodSCAN IgG ELISA Food Intolerance
Test, removing the offending foods from the diet, together with
nutritional and dietary support and advice offered by York Nutritional
Laboratories, IBS patients can find symptomatic relief and increase
their quality of life. This may also save many millions of dollars in
attempts to treat this condition.

John Kernohan, Director of York Nutritional Laboratories says, "We are
so pleased and proud to be able to offer such a simple but effective
solution to the many thousands of sufferers of IBS, which does not
involve expensive and often ineffective medication. From just a simple
pinprick of blood, at long last this is a solution, which means that
many patients can help themselves by simple dietary change and no
medication or unnecessary procedures. Food has been implicated for many
thousands of years to have an effect on our health, and at last we
seeing this proven in a clinical and scientific manner."

For more information on any of York Nutritional Laboratories
finger-stick tests for food intolerance, gluten sensitivity and Celiac
Disease, or to receive an abstract of the University Hospital of South
Manchester's Double-Blind, Placebo-Controlled Study, please contact John
Kernohan, York Nutritional Laboratories Inc., 2700 North 29th Avenue,
Suite # 205, Hollywood, Florida 33020 USA. Tel: 888/751-3388, Email:
[log in to unmask], http://www.yorkallergyusa.com.

*Support summarization of posts, reply to the SENDER not the CELIAC List*